Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998;15(4):279-84.
doi: 10.2165/00044011-199815040-00003.

Pharmacokinetics and efficacy of low-dose ketoprofen in postoperative dental pain

Affiliations

Pharmacokinetics and efficacy of low-dose ketoprofen in postoperative dental pain

R A Seymour et al. Clin Drug Investig. 1998.

Abstract

A double-blind, randomised trial was carried out to investigate the relationship between efficacy and various pharmacokinetic variables after single doses of racemic ketoprofen 12.5 and 25mg in patients with postoperative pain after third molar surgery over a 4-hour investigation period. Serial venous blood samples were obtained at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3 and 4 hours after administration for subsequent determination of R(-) and S(+) ketoprofen. The relationship between the R(-) and S(+) ketoprofen concentrations and pain experience was summarised for each patient by the slope of the regression line for that individual. There was no significant difference (p > 0.05) between the two doses of ketoprofen for any of the efficacy measures. Peak plasma concentrations of both R(-) and S(+) ketoprofen were observed between 60 and 90 minutes after dosage. A significant negative correlation (p < 0.002) was observed between the decrease in pain scores and plasma concentrations of both R(-) and S(+) ketoprofen after each dose. However, the amount of variability in each patient's response makes it difficult to identify a causal relationship between these parameters. Low doses of ketoprofen provide satisfactory pain relief in the early postoperative period after third molar surgery. Efficacy of this analgesic does not appear to be dose related or directly related to plasma concentrations of either R(-) or S(+) enantiomers.

PubMed Disclaimer

References

    1. Br J Oral Maxillofac Surg. 1993 Dec;31(6):360-5 - PubMed
    1. BMJ. 1990 Jan 27;300(6719):230-5 - PubMed
    1. Clin Pharmacol Ther. 1986 Jul;40(1):1-7 - PubMed
    1. Br J Clin Pharmacol. 1993 Sep;36(3):185-93 - PubMed
    1. Br J Clin Pharmacol. 1995 Sep;40(3):266-9 - PubMed

LinkOut - more resources